Introduction: Ethical Responsibilities Regarding Drugs, Patents, and Health

Publisher： Cambridge University Press

E-ISSN： 2153-3326|15|4|543-547

ISSN： 1052-150x

Source： Business Ethics Quarterly, Vol.15, Iss.4, 2005-10, pp. : 543-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patents, brand-generic competition and the pricing of ethical drugs in Canada: some empirical evidence from British Columbia, 1981-1994

By Jones J. C. H.   Potashnik Tanya   Zhang Anming  

Applied Economics, Vol. 33, Iss. 7, 2001-06 ,pp. : 947-956

Routledge Ltd

Access to resources Recommend Favorite

Patents and the Global Diffusion of New Drugs

By Cockburn Iain M.   Lanjouw Jean O.   Schankerman Mark  

The American Economic Review, Vol. 106, Iss. 1, 2016-01 ,pp. : 136-164

American Economic Association

Access to resources Recommend Favorite

Introduction to the Special Issue: Globalization as a Challenge for Business Responsibilities

By  

Business Ethics Quarterly, Vol. 19, Iss. 3, 2009-07 ,pp. : 327-347

Cambridge University Press

Access to resources Recommend Favorite

Pricing and patents of HIV/AIDS drugs in developing countries

By Borrell Joan-Ramon  

Applied Economics, Vol. 39, Iss. 4, 2007-03 ,pp. : 505-518

Routledge Ltd

Access to resources Recommend Favorite

Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis

By  

Business Ethics Quarterly, Vol. 15, Iss. 4, 2005-10 ,pp. : 549-575

Cambridge University Press

Access to resources Recommend Favorite